Jan 7 (Reuters) - The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc's experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday. (https://bit.ly/35BGW3Z) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.11 USD | +1.16% | +10.17% | +173.12% |
Jul. 02 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
Jul. 02 | Novavax: Health Canada approves Covid 24/25 vaccine | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+173.12% | 1.84B | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax : Australia enters agreement to buy 51 mln doses of Novavax's COVID-19 vaccine